CEO Sabrina Johnson stated that "Daré is at an inflection point. The third quarter of 2025 reflects the continued acceleration of our dual path strategy as we focus on closing the gap in women's ...
Daré Bioscience announces a webinar on DARE to PLAY™, a sildenafil cream for female sexual arousal, launching in Q4 2025. A first-of-its-kind topical formulation of sildenafil for women, potentially ...
Daré Bioscience secures $6 million funding for DARE-LARC1, a contraceptive leveraging advanced drug delivery technology, totaling $37.8 million received. Daré Bioscience, Inc. has announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results